Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
CALL
Markel Group
MKL
$22.4B
| $38M | 0.01% |
20,300
-400
| -2% | -$736K |
|
1202
CALL
Roper Technologies
ROP
$40.9B
| $37.9M | 0.01% |
64,300
+27,800
| +76% | +$15.6M |
|
1203
CALL
Tradeweb Markets
TW
$22.7B
| $37.9M | 0.01% |
255,000
+53,600
| +27% | +$7.12M |
|
1204
Samsara
IOT
$22.8B
| $37.8M | 0.01% |
987,370
+718,166
| +267% | +$33.4M |
|
1205
CALL
SAP
SAP
$250B
| $37.8M | 0.01% |
140,900
+51,200
| +57% | +$13.9M |
|
1206
PUT
Brinker International
EAT
$10.7B
| $37.7M | 0.01% |
253,200
-72,000
| -22% | -$11.1M |
|
1207
ProShares UltraPro QQQ
TQQQ
$35.4B
| $37.7M | 0.01% |
1,314,580
+667,054
| +103% | +$25.3M |
|
1208
CALL
Direxion Daily FTSE China Bear 3X ETF
YANG
$101M
| $37.6M | 0.01% |
950,100
-1,066,300
| -53% | -$55.1M |
|
1209
Monolithic Power Systems
MPWR
$64.1B
| $37.6M | 0.01% |
64,842
+13,131
| +25% | +$8.27M |
|
1210
CALL
West Pharmaceutical
WST
$24.5B
| $37.4M | 0.01% |
167,200
+33,500
| +25% | +$9.23M |
|
1211
State Street SPDR S&P Biotech ETF
XBI
$11.8B
| $37.4M | 0.01% |
461,312
+95,418
| +26% | +$8.53M |
|
1212
PUT
Seagate
STX
$186B
| $37.4M | 0.01% |
440,100
-134,200
| -23% | -$12.7M |
|
1213
CALL
CRH
CRH
$64B
| $37.4M | 0.01% |
424,900
-595,400
| -58% | -$58.6M |
|
1214
PUT
Advance Auto Parts
AAP
$2.63B
| $37.2M | 0.01% |
949,300
+101,900
| +12% | +$4.37M |
|
1215
TechnipFMC
FTI
$29.5B
| $37.2M | 0.01% |
1,174,500
+208,609
| +22% | +$6.25M |
|
1216
Iris Energy
IREN
$15.1B
| $37.2M | 0.01% |
6,111,529
+1,906,385
| +45% | +$18.6M |
|
1217
CALL
Otis Worldwide
OTIS
$27.2B
| $37.2M | 0.01% |
360,600
-317,100
| -47% | -$31M |
|
1218
PUT
GitLab
GTLB
$7.04B
| $37.2M | 0.01% |
790,600
+232,200
| +42% | +$14.2M |
|
1219
PUT
XP
XP
$9.03B
| $37.1M | 0.01% |
2,698,300
+2,438,400
| +938% | +$33.6M |
|
1220
CALL
Ecolab
ECL
$81.2B
| $37.1M | 0.01% |
146,200
+34,000
| +30% | +$8.57M |
|
1221
CALL
iShares Biotechnology ETF
IBB
$10.9B
| $37M | 0.01% |
289,600
-62,100
| -18% | -$8.42M |
|
1222
Rivian
RIVN
$24.2B
| $37M | 0.01% |
2,969,181
+2,454,340
| +477% | +$30.9M |
|
1223
Direxion Daily FTSE China Bull 3X ETF
YINN
$676M
| $36.9M | 0.01% |
890,630
+784,711
| +741% | +$29.2M |
|
1224
CALL
Colgate-Palmolive
CL
$72.8B
| $36.8M | 0.01% |
392,900
-430,100
| -52% | -$38.5M |
|
1225
PUT
Equifax
EFX
$22.5B
| $36.8M | 0.01% |
151,100
+133,900
| +778% | +$33.7M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.